The Latest Breaking News from Becton Dickinson

Edwards Lifesciences stock rallied Monday on medtech giant Becton Dickinson's plan to buy a key division for $4.2 billion.

What you need to know… The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed down -0.15%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.42%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.17%. Stocks on Tuesday settled mixed. Reduced expectations for...

Becton, Dickinson's (NYSE:BDX) short percent of float has fallen 9.33% since its last report. The company recently reported that it has 3.87 million shares sold short, which is 1.36% of all regular shares that are available for trading.

Becton, Dickinson (NYSE:BDX) has outperformed the market over the past 10 years by 1.98% on an annualized basis producing an average annual return of 12.93%. Currently, Becton, Dickinson has a market capitalization of $70.95 billion.

Within the last quarter, Becton, Dickinson (NYSE:BDX) has observed the following analyst ratings:

Upgrades

Becton, Dickinson's (NYSE:BDX) short percent of float has risen 11.94% since its last report. The company recently reported that it has 4.25 million shares sold short, which is 1.5% of all regular shares that are available for trading.

Becton, Dickinson (NYSE:BDX) has outperformed the market over the past 20 years by 3.34% on an annualized basis producing an average annual return of 10.37%. Currently, Becton, Dickinson has a market capitalization of $71.95 billion.

Becton Dickinson and Co (NYSE:BDX) will acquire Parata Systems from Frazier Healthcare Partners for $1.525 billion.  Parata offers a portfolio of pharmacy automation solutions to reduce costs, enhance patient safety and improve the patient experience.  Significant macro trends such as clinician shortages, wage inflation, centralization of pharmacy services, and increased clinical demands…